Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Anjali Morey

Gastroenterology Kettering, OH Medical Doctor

NPI 1770722605 CMS profile 926387

999 Brubaker Dr, Digestive Specialists INC, Kettering, OH 45429

Open in the dashboard

General payments

$139,708

543 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$424,798 paid to institutions, not to them · program years 2021–2025

Through program year 2025, Anjali Morey of Kettering, OH is reported in the CMS Open Payments database as having received $139,708 across 543 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $424,798 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 97th percentile of Gastroenterology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $84,818 130
2024 General $36,415 141
2023 General $3,520 117
2022 General $4,051 101
2021 General $3,395 45
2020 General $119 1
2019 General $7,389 8

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Anjali Morey
  • Gastroenterology median
  • Middle half of Gastroenterology
  • National median

In program year 2025, general payments to Anjali Morey were reported at $84,818. Among 13,050 Gastroenterology profiles paid that year, the median was $639 and the middle half received between $167 and $1,700.

Show as a table
Year Anjali Morey Gastroenterology median Middle half National median
2019 $7,389 $417 $126–$1,100 $163
2020 $119 $224 $74–$624 $114
2021 $3,395 $352 $106–$1,054 $132
2022 $4,051 $448 $129–$1,270 $149
2023 $3,520 $533 $150–$1,390 $160
2024 $36,415 $605 $160–$1,606 $164
2025 $84,818 $639 $167–$1,700 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Madrigal Pharmaceuticals $57,830 54 payments
  2. Novo Nordisk Inc $34,231 25 payments
  3. Phathom Pharmaceuticals, Inc. $24,782 44 payments
  4. AbbVie, Inc. $15,530 155 payments
  5. Salix Pharmaceuticals, a division of Bausch Health US, LLC $1,580 88 payments
  6. Takeda Pharmaceuticals U.S.A., Inc. $989 51 payments
  7. Regeneron Pharmaceuticals, Inc. $871 7 payments
  8. Janssen Biotech, Inc. $622 32 payments
  9. QOL Medical, LLC $603 23 payments
  10. Lilly USA, LLC $552 8 payments
  11. Other $2,117 56 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $109,170 34 payments
  2. Food and Beverage $16,950 471 payments
  3. Travel and Lodging $12,556 35 payments
  4. Consulting Fee $968 1 payment
  5. Education $65 2 payments
Products named General payments · program years 2019–2025
  1. REZDIFFRA Liver Disease $41,237 38 payments
  2. Wegovy $34,219 24 payments
  3. VOQUEZNA $24,716 40 payments
  4. REZDIFFRA Liver Disease $15,485 13 payments
  5. HUMIRA $6,622 30 payments
  6. RINVOQ $3,091 55 payments
  7. XIFAXAN $1,196 64 payments
  8. DUPIXENT $867 14 payments
  9. ENTYVIO $698 37 payments
  10. LINZESS $642 36 payments
  11. Other $6,419 235 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

543 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Gastroenterology in Ohio

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record